Repeat Offenders—CLU, CR1, PICALM Hold Up in Association Studies
“we should be able to map these risk loci onto biochemical pathways,” they write.—Esther Landhuis
373 RESULTS
You searched Esther AND Landhuis
Sort By:
“we should be able to map these risk loci onto biochemical pathways,” they write.—Esther Landhuis
of the disease genes are,” he said. “There’s no simple road.”—Esther Landhuis None
ARF.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1966 Alzheimer's Disease Sirtuins
are safe.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1962 Alzheimer's Disease Sirtuins Tau
story on Feng et al., 2008).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2813 Amyloid
in accumulation of inactive MEF2D in the cytoplasm, leaving the neurons more susceptible to death.—Esther Landhuis
of this story.—Esther Landhuis See also Part 2 of this story. None http://www.alzforum.org/new/detail.asp?id=1867
or neurodegeneration.”—Esther Landhuis This is Part 1 of a three-part series. See also Part 2 and Part 3. Download a PDF
mitochondrial distribution abnormalities can lead to synaptic deficits in vivo.—Esther Landhuis None
trade name Chantix as a smoking cessation patch.—Esther Landhuis None
bursts could thus be interesting to pursue, Sarter said.—Esther Landhuis. This story concludes
of APOE4.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1911 Alzheimer's Disease Clinical
the Japanese study.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2545 Alzheimer's
doing imaging on a receptor-based level in humans,” Morrison speculated.—Esther Landhuis None
Biotechnology Ltd., the Australian biotech company that sponsored the trial.—Esther Landhuis None